ASSEMBLY BIOSCIENCES, INC. - 10-Q Filing
Assembly Biosciences filed a 10-Q for the first quarter of 2025, disclosing financial and operational details including a collaboration agreement with Gilead Sciences involving regulatory and commercial milestones with a maximum potential value. The filing also outlines financial instruments, stock-related activities, and fair value measurements for various assets.
Tickers: $ASMB